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Abstract 
 
Insulin is now established as a key regulator of brain mechanisms that include both glucose 
metabolism and synaptic plasticity, especially within the hippocampus.  However, the complex 
set of signaling cascades mediating these effects is not yet understood.  Recent studies, many 
from our lab, have established that insulin plays multiple roles in the brain: in addition to 
regulation of energy supply, metabolism, and feeding, our work has shown that hippocampal 
insulin is a key modulator of learning and memory.  Exogneous insulin enhances, while 
pharmacological blockade of intrahippocampal insulin impairs, both metabolism and cognition.  
Moreover, when systemic insulin signalling is impaired, such as in Type 2 diabetes, hippocampal 
function and metabolism are again impaired. Memory processes both in the hippocampus and 
elsewhere (e.g. amygdala) are well established to be sensitive to glucose supply: performance on 
memory tasks is limited by glucose availability, and provision of additional glucose supports 
enhanced task performance.  Systemically, insulin regulates glucose transport from the blood 
into cells; conversely, glucose regulates insulin synthesis and release from the pancreas, so that 
the two molecules mutually regulate. Although this relationship between insulin and glucose has 
been well studied, there has been little work on their interaction in the brain.  For instance, 
although we have shown that insulin regulates hippocampal glucose metabolism, it is unknown 
whether glucose acts to enhance memory via stimulation of insulin release within the 
hippocampus, or whether insulin's procognitive effects are via stimulation of glucose metabolism 
or a direct modulation of plasticity.  In this study, Glut4, an insulin-dependent glucose 
transporter found on some hippocampal neurons, was directly blocked. Indinavir, a Glut4 
inhibitor, was injected directly into the dorsal hippocampus of rats in the presence or absence of 
a peritoneal glucose injection in order to assess changes in cognition. It was found that indinavir 
treatment significantly impaired cognition in spontaneous alternation tasks, reduced anxiety, and, 
surprisingly, and had no effect on cognitive performance in a novel object recognition task.  
These data support a novel role for GluT4 as a mediator of hippocampal memory processing and 
suggest that insulin acts to regulate cognitive function at least in part via GluT4-mediated 
glucose transport into neurons.  In the presence of indinavir, glucose was unable to enhance 
memory, consistent with this interpretation and suggesting that enhancement of hippocampal 
memory by glucose may require hippocampal insulin signaling.  Post-mortem molecular studies 
of hippocampal protein expression provided further insight into the molecular impact of both 
glucose treatment and GluT4 blockade. 
 
 
 
 
 
 
 
 
Introduction:  
Glucose is well known as the main fuel source of the brain. Cognitive demand leads to decreased 
glucose concentrations during spatial memory tasks, with glucose demands directly 
corresponding to the complexity of the task (McNay et al., 2000). This study indicates that the 
limitation imposed on memory processing is the concentration of glucose, with a specific focus 
on the hippocampus. Metabolically, it is widely known that upon increase in systematic glucose 
concentration, following a meal for example, insulin is released to lower glucose concentration; 
the aim of the body is to maintain homeostasis of fuel supply. 
In addition to studies linking the effect of glucose to cognition, insulin’s role on similar 
tasks has been studied as well. Literature focuses on both the physiological disorders involving 
impaired insulin signaling, as well as on specific alteration of insulin signaling on the cellular 
level. For instance, diabetes mellitus type 2 (T2DM) is a metabolic disorder where the lack of 
insulin sensitivity leads to hyperglycemia. Patients suffering from T2DM have been seen to 
experience progressive cognitive deficits (Cukierman et al., 2005). Further, it has been shown 
that hyperinsulinemia associated with T2DM makes patients more susceptible to developing 
Alzheimer’s disease (Kroner, 2009).  Excess insulin has been linked to the accumulation of beta 
amyloid, as the two molecules share a breakdown pathway.  
Studies on the cellular and molecular levels make a connection between insulin activity 
and learning and memory processes. Evaluation of insulin signaling in the central nervous 
system revealed the presence of insulin receptors distributed throughout the hippocampus (Zhao 
et al., 1999) alluding to a significant role of insulin receptors on memory processing. Further, 
direct administration of insulin to the hippocampus was shown to enhance cognitive function in 
spatial memory tasks. The same study showed that administration of increasing concentrations of 
insulin versus cognitive function yields a graph shaped like an inverted U, indicating an optimal 
level of insulin for cognition. Alteration from this optimal level leads to cognitive impairments 
(McNay et al., 2010). Furthermore, intranasal insulin administration in humans improved 
memory performance, suggesting a potential treatment for Alzheimer’s disease (Benedic et al., 
2004).  
Insulin signaling is a complex pathway that has yet to be completely understood. It is 
known that the activation of insulin receptors via the dimerization of tyrosine residues involves 
an increase of P13K activity, a kinase involved in cell growth, proliferation, and differentiation. 
Moreover, it has been recently shown that using insulin-like growth factor affects the 
phosphorylation of CREB, which is correlated to memory enhancement (Alberini and Chen, 
2012). Another key player in insulin signaling is GluT4. In contrast to various other cellular 
glucose transporters, GluT4 is an insulin-dependent glucose transporter found in the 
hippocampus. Recently, the activation of GluT4 is thought to be the connection between 
insulin’s effects on cognitive function as described above. GluT4 is the main molecular target in 
the present study. Using Indinavir, a drug previously used for the treatment of HIV/AIDS, and a 
GluT4 antagonist, this study directly alters hippocampal insulin signaling and measures its effect 
on cognitive function.  
Glucose and insulin both play significant roles in cognitive processes, as indicated by the 
memory enhancement produced separately by the administration of each molecule into the 
hippocampus. Given their interdependent actions systematically, it is imperative then to further 
our understanding of the way these molecules work together to affect cognition. One may ask 
two questions; is the effect of glucose on memory a product of insulin signaling? Or, on the 
contrary, is the effect of insulin on memory mediated by the presence of glucose? This current 
study tackles the first question: in order to investigate if memory is dependent on insulin 
signaling within the brain, subjects were divided into two groups either receiving a 
microinjection of indinavir or aECF directly into the dorsal hippocampus. Each group was 
further divided into glucose or saline receiving groups, where the treatment was co-administered 
by peritoneal microinjection. Using this method, this study indirectly tests the dependency of 
insulin on the effect of glucose on memory by ceasing the uptake of glucose into the cell.  
 In order to measure cognition, three behavioral tasks were performed: spontaneous 
alternation, novel object recognition, and open field task. Administration of indinavir resulted in 
a significant decrease in percent alternation in a four-armed maze, and a reduction in anxious 
behavior in comparison to subjects receiving aECF. The administration of glucose did not 
significantly affect behavior in spontaneous alternation and novel object recognition tasks. 
However, glucose administration in open field tasks seemed to ameliorate the effect of indinavir. 
The effects of co-administration of glucose and indinavir were not significantly different from 
that of glucose and saline co-administration with aECF. Collectively, this data indicates that 
GluT4, and hence insulin signaling, plays a key role in cognition. In regards to glucose 
administration, the data presented in this study is inconsistent with previous studies; it was 
expected that subjects receiving glucose would show enhancement in memory performance in 
comparison to the aECF/saline-administered groups, and to the two groups receiving the 
indinavir treatment. The lack of differences between the indinavir-administered groups indicates 
the need for further studies. Molecular studies of essential hippocampal proteins involved in 
insulin signaling and learning and memory are currently in progress.   
  
Methods:   
Animals:  
40 Male Sprague-Daley rats (Charles River) were studied, arriving at 10 weeks of age. Rats were 
individually housed with food and water available on a 12:12h light:dark schedule. Room/cage 
temperature was maintained at 25 degrees Celsius. Animals were handled 5 minutes every day a 
week prior to surgery, which was done 10 days following animal arrival. Rats were handled 
everyday post-surgery until behavioral testing and animal sacrifice were done a week following 
surgery. All animal were randomly assigned group during behavioral testing day. All procedures 
were approved by the University at Albany, SUNY, animal care facility.  
Surgery: 
 Rats were anesthetized with isoflourine (5% by air) before surgery with oxygen was delivered at 
the same time. Throughout the duration of the procedure isoflourine was lowered to 3% and 
oxygen was lowered to 2%. All animals received a microinjection guide cannula directly into the 
left hippocampus with coordinate relative to bregma: 5.2 mm posterior to bregma, +4.8 lateral, 
and 3.8 ventral from dura. The Nose-bar was set to 5mm above the interaural line. Rats received 
4mL injection of sterile saline (1mL before and 3mL after surgery). During surgery a 1:1 
epinephrine/marcain was administered drop-wise to prevent the bleeding. Directly following 
anesthetic removal, rats were placed in a warm incubator until recovery from anesthesia. 
Animals receive 5mg/kg dose of rimadyl right after surgery and a 2 mg rimidyl tablet for three 
days post surgery. Animals were recovering for a week post surgery where they are handled for 5 
minutes everyday.  
Intraperitoneal injection procedure: 
 Injection was given using a 3mL syringe and administrated to the left abdomen of each rat. 
Injection was given 10 minutes prior to the start of behavioral testing directly preceding 
microinjections. Injections were given according to body weight taken prior to injection 
250mg/kg glucose in saline. Saline was given as control. 
Microinjection procedure:  
Rats were injected with either Indinavir sulfate (Toronto Research Chemicals, Inc) or aECF 
(aECF; 153.5 mM Na, 4.3 mM K, 0.41 mM Mg, 0.71 mM Ca, 139.4 mM Cl, buffered at pH 7.4; 
(McNay and Sherwin, 2004)) following an i.p. injection of either glucose or saline. Indinavir was 
brought to final concentrations of 100nM in artificial extracellular fluid (aECF), HCl was used 
drop-wise to allow indinavir to go into solution and a pH 6 was measured for all animals 
including aECF receiving groups. Microinjections were administered to the dorsal hippocampus 
10 min prior to behavioral testing at a flow rate of 1.25 µl/min for a total volume of 0.5 µl. 
Solution took 4 minutes to enter the brain area and the probe was left for an additonal 2 minutes 
to make sure no residual solution is left in the probe. Rats enter the maze 10 minutes after the 
start of injection. 
Behavioral testing:  
Spontaneous Alternation (SA): the animals were placed in the middle of a four-arm maze, facing 
the same direction each time. It was noted every time an animal moved to a new arm or showed 
interest by placing more than half of their body in the arm. The spontaneous alternations were 
recorded for 15 minutes. An alternation is counted when the subject visited all 4 arms within a 
span of 5 consecutive arm choices. The actual number of alternation made is expressed as a 
percentage to the total numbers of arms entered. The animals were allowed 5 minutes to rest post 
task where they were placed back in their cage. The maze was cleaned with 70% ethanol 
between each animal and at the start of testing day. 
Novel Object Recognition:  
training took place 5 minutes after SA. For the training phase the animals were placed in a clear 
box with two of the same objects orientated and placed in the same way. Time was collected 
every time the animal showed interest in the object by investigating/sniffing it. Animal 
interactions with both the left and right objects were recorded for 5 minutes. The animals were 
allowed 30 minutes of rest back in their home cages. After 30 minutes the animals were placed in 
the same box with a novel object and one of the familiar object. The same measurements were 
collected as in training. The novel object was randomized between placements. The box was 
cleaned with 70% ethanol between each animal. 
Open field: the animals were placed in a box that has 16 squares drawn on it. Every time the 
animals were in the middle 4 boxes the time was collected. Animals were in the box for five 
minutes. The box was cleaned with 70% ethanol prior to testing and between animals. Rats were 
sacrificed following the task. 
Sacrifice and Tissue collection:  
animals were anesthetized using isoflourine and after ensuring unconsciousness rats were 
guillotined. Blood samples were collected as well as the left and right hippocampus and 
prefrontal cortex.  
Tissue preparation:  
Following collection hippocampus tissues were immediately transferred to 150uL of 
homogenization buffer and were treated with handheld tissue grinder. Sampled were divided into 
total and plasma membrane. 30uL of the homogenized tissue were placed in 100uL Ripa buffer 
to prepare the total sample. Plasma membrane samples that were only placed in homogenized 
buffer were further processed using membrane extraction protocol.  
Statistical Analysis:  
All tests were conducted using two-tailed, unpaired t-tests or one-way analysis of variance 
(ANOVA) with individual group differences versus control determined by Dunnett’s Multipe 
Comparison post hoc tests. Significance was taken >0.05. N of each behavioral group was 
between 8-10. 
 
Results: 
Indinavir administration impaired spatial memory performance: Through trials of spontaneous 
alternation tasks, it was shown that the two groups administered indinavir scored significantly 
lower than those administered aECF (p=0.0049).  
 
 
 
 
 
 
 
 
 
 
 
Indinavir administration decrease anxious behavior: Through trials of open field tasks, general 
locomotive activity, exploratory behavior, and anxiety were measured. By comparing the 
percentage of time that the rats spent in the middle four squares in comparison to the edges, it 
was found that indinavir administered rats were significantly less anxious than rats receiving 
aECF, evidenced by the significantly higher percentage spent in the middle squares (p=0.029). 
Additionally, within the group of the rats administered indinavir, co-administration of glucose 
significantly decreased the effect observed in the absence of glucose (p=0.0244). No significant 
differences were found between the indinavir/glucose group and the aECF/glucose group. 
 
 
Indinavir did not significantly affect recognition memory: In order to test memory recognition, 
rats were presented with a two-object recognition task. It was found that upon administration of 
indinavir, the subject’s ability to recognize objects significantly improved. 
 
 
 
 
 
 
 
 
 
 
 
Discussion  
Previous studies in the field of learning and memory directly correlate the effect of both insulin 
and glucose to cognitive enhancement. It is known that in the periphery, these molecules directly 
affect one other, but little work has been done focusing on their interaction in the brain. The 
present study suggests that the effects of these molecules on cognition are not independent of 
each other; rather, the presence of one causes the observed cognitive effect upon sole 
administration of the other. The question arises as to which one is responsible. Here, we begin by 
looking at insulin as the main modulator and ask whether enhancement of glucose on cognition 
is a result of insulin signaling. In order to alter insulin signaling, we focused specifically on 
GluT4, an insulin dependent glucose transporter. GluT4 is known to be present in the 
hippocampus and causes upregulation of memory formation upon administration. We used the 
GluT4 antagonist, indinavir. 
Due to previous studies on GluT4, it was expected that administration of indinavir would 
cause impairment in cognitive performance. We also expected that glucose administration alone 
would enhance cognition, as previously shown. We used spontaneous alternation tasks as a 
measure of spatial memory processing, novel object recognition as a cognitive task for 
recognition memory, and open field tasks as a measure for anxious behavior.  
As expected, indinavir administration significantly decreased cognitive performance in 
comparison to a control group in spatial working memory tasks. Co-administration of glucose 
and indinavir yields the same results as administration of indinavir with saline. This provides the 
possibility that glucose effect on memory is indeed insulin dependent, since indinavir treatment 
was not affected by glucose treatment. However, the administration of glucose alone (aECF 
microinjection) did not affect memory as expected if the cognitively ameliorative effect of 
glucose is dependent on insulin signaling, because proper insulin signaling is still intact. This 
raises the question of whether the lack of effects seen in the indinavir group is actually due to the 
dependency of glucose on indinavir, or rather, a lack of effect of glucose in this study.  
 Since it was previously shown that glucose levels significantly decrease during memory 
tasks, and administration of glucose significantly improves cognitive tasks, we question the 
effect of glucose in this study. One possibility for our lack of effect could be that simply not 
enough glucose was given to cause improvement of performance, and perhaps an additional 
study should be carried out with administration of higher glucose concentrations. Another 
possibility is that since glucose decline is associated with cognitive demands, it is possible that 
the four-armed maze was not complex enough to result in a significant decrease in glucose. The 
latter explanation is the most probable one; by observing the result of the SA task one can see 
that the control animals reached nearly 80% alternation. In the previously reported studies the 
controls reached about 50% alternation. This comparison suggests that the maze setup in the 
facility is not challenging enough for the animals. These results are rather inconclusive because 
the controls do not show consistent results as seen in previous studies. We are interested in 
investigating this odd occurrence by carrying out a simple study of administering glucose or 
insulin to subjects to obtain a better understanding of these inconsistencies concerning the effect 
of glucose.  
Open field tasks also showed significant differences between the indinavir and aECF 
groups. The indinavir/saline treated group showed significantly less anxiety by spending more 
time in the center of the field in comparison to the control. Furthermore, groups administered 
indinavir/glucose were significantly more anxious than those that received indinavir in the 
absence of glucose. Statistically, this group was comparable to both groups that did not receive 
indinavir. This might suggest a potential role of glucose in balancing or protecting anxious 
behavior; it can be seen that a significant decrease in anxious behavior was brought back to 
baseline upon administration of glucose along with the agent that lowered anxiety. This 
hypothesis may also explain the lack of effects seen in the administration of glucose alone in 
comparison to the control. Open field task was the only task in which the administration of 
glucose showed a significant effect.  
Taken together, the presented behavioral testing data demonstrate the importance of 
GluT4 in cognition, further showing the importance of downstream hippocampal insulin 
signaling in such processes. However, we cannot conclude whether the known effect of glucose 
on cognition is insulin dependent due to the inconsistent results obtained from our controls.  
In order to further investigate the effect of indinavir and glucose on cellular and 
molecular processes, we are currently working on western blotting for protein analysis in the 
hippocampus. The target proteins are those directly participating in insulin signaling, including 
Akt, p-Akt, P13K, and Glut4, as well as proteins involved in learning and memory, including 
NMDA-R, AMPA-R, CREB, and their phosphorylated counterparts.  
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